Emcure Pharma shares up 5% after Jefferies initiates 'Buy' rating
Open Demat A/C Jefferies sets ₹1,600 target for Emcure Pharma, indicating a 15% upside potential
Open Demat A/C
Emcure Pharma stock is up 40% from the issue price of ₹1,008
Open Demat A/C Emcure Pharma shares surge 5% to record high of ₹1,455.20 following 'Buy' rating
Open Demat A/C Emcure Pharma projects 11% annual revenue growth and 29% profit CAGR from FY24 to FY27
Open Demat A/C Emcure Pharma achieves 11% revenue growth in FY24, reaching ₹6,715 crore
Open Demat A/C Emcure Pharma FY24 profit falls 6% to ₹527 crore, down from ₹561 crore
Open Demat A/C With Our Subscription Plans
Open demat account in 5 minutes*
Open Demat A/C G-L92HWH8MZR